Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-027943
Filing Date
2023-03-02
Accepted
2023-03-02 16:25:55
Documents
5
Effectiveness Date
2023-03-02

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm237170d1_s8.htm S-8 43938
2 EXHIBIT 5.1 tm237170d1_ex5-1.htm EX-5.1 12450
3 EXHIBIT 23.1 tm237170d1_ex23-1.htm EX-23.1 1861
4 EX-FILING FEES tm237170d1_ex-filingfees.htm EX-FILING FEES 12963
5 GRAPHIC tm2371701_ex5-1img01.jpg GRAPHIC 15640
  Complete submission text file 0001104659-23-027943.txt   93935
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270226 | Film No.: 23699367
SIC: 2834 Pharmaceutical Preparations